Nasal Antisepsis for C. Auris Prevention
This is a randomized, controlled, open-label trial of effect of 10% povidone iodine intranasal antisepsis on the detection of Candida auris.
- EligibilityCriteria: Inclusion Criteria:  History of C. auris colonization or infection Patient in a participating facility  Exclusion Criteria:  History of severe allergy to iodine-based products, defined as anaphylaxis or rash Currently breastfeeding or pregnant Non-English language speaking - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult